Latest news with #U.S.FarmBill
Yahoo
13-05-2025
- Business
- Yahoo
Cannabidiol Market to Hit $22.05 Billion by 2030 at CAGR 15.8% - Grand View Research, Inc.
SAN FRANCISCO, May 13, 2025 /PRNewswire/ -- The global cannabidiol market size is expected to reach USD 22.05 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2025 to 2030. Changing consumer attitudes towards CBD products, shifting public opinion, and growing recognition of the health benefits of cannabidiol are some of the main factors contributing to the market's growth. The cannabis Sativa plant contains more than 80 cannabinoids, but cannabidiol is the most widely used for medical purposes because of its lack of psychoactive effects. It is primarily obtained from hemp due to its high CBD content. There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings. Request a free sample copy or view report summary: Cannabidiol Market Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named "HM Pharma" to expand its access to CBD products in pharmacies. Cannabidiol Market Report Highlights: North America accounts for the largest with a market share of 86.7% in 2024 owing to the presence of major manufacturers, and approval of the U.S. Farm Bill are some of the major factors driving the growth of the region. Hemp-derived CBD dominated the market in 2024, with a market share owing to its higher purity and potential health benefits. B2B segment accounts for the largest market share in 2024 owing to increasing demand and a rising number of businesses using cannabidiol as raw materials. In 2023, the pharmaceuticals segment accounted for the largest market share in the end-use market owing to rising use of cannabis derivate for various medical conditions. Read full market research report on Cannabidiol Market with TOC - Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2025 - 2030 Cannabidiol Market Segmentation Grand View Research has segmented the global cannabidiol market based on source type, sales type, end-use, and region: Cannabidiol (CBD) Market - Source Type Outlook (Revenue, USD Million, 2018 - 2030) Hemp Marijuana Cannabidiol (CBD) Market - Sales Type Outlook (Revenue, USD Million, 2018 - 2030) B2B By End-use Pharmaceuticals Wellness Food & Beverages Personal Care & Cosmetics Nutraceuticals Others B2C By Sales Channel Hospital Pharmacies Online Retail Stores By End-use Medical Chronic Pain Mental Disorders Cancer Others Personal Use Cannabidiol (CBD) Market - End-use Outlook (Revenue, USD Million, 2018 - 2030) Medical Personal Use Pharmaceuticals Wellness Cannabidiol (CBD) Market - Regional Outlook (Revenue, USD Million, 2018 - 2030) North America Europe Asia Pacific Latin America Middle East & Africa (MEA) List of Key Players in the Cannabidiol Market ENDOCA Cannoid, LLC Medical Marijuana, Inc. Folium Europe B.V. Canopy Growth Corporation Elixinol NuLeaf Naturals, LLC Isodiol International, Inc. PharmaHemp The Cronos Group Check out more related studies published by Grand View Research: U.S. Cannabinoids Market - The U.S. cannabinoids market size is expected to reach USD 60.36 billion by 2030, registering a CAGR of 15.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing number of consumers opting for isolated cannabinoid products aided by growing clinical studies to understand and expand applications associated with cannabinoids is driving the growth of the overall market in the U.S. Latin America And Caribbean Hemp-Derived Cannabidiol Market - The Latin America and Caribbean hemp-derived cannabidiol market size is estimated to reach USD 524.39 million by 2030, expanding at a CAGR of 18.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The LATAM and Caribbean regions have a huge potential to become the leader in hemp and cannabidiol space owing to the vast agriculture industry, low labor, and construction costs. North America Hemp-derived Cannabidiol Market - The North America hemp-derived cannabidiol market size is expected to reach USD 3.1 billion by 2030. It is expected to expand at a compound annual growth rate (CAGR) of 13.5% over the forecast period, according to a new report by Grand View Research, Inc. Growing awareness and adoption of cannabidiol (CBD) for various health conditions are the key factors driving the growth of this market. Mexico Hemp CBD Market - The Mexico hemp CBD market size is projected to reach USD 74.3 million by 2030, expanding at a revenue-based CAGR of 26.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The recent approval by the Mexico government for the usage of medical cannabis and cannabidiol-derived products containing less than 1% Tetrahydrocannabinol (THC) is driving the market. Browse Horizon Databook on Cannabidiol Market – Global Cannabidiol Market Size & Outlook About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics. Contact: Sherry JamesCorporate Sales Specialist, USAGrand View Research, 1-415-349-0058Toll Free: 1-888-202-9519Email: sales@ Us: LinkedIn | TwitterBlog - Logo: View original content: SOURCE Grand View Research, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-03-2025
- Business
- Yahoo
Backers of hemp regulation bill say intoxicating hemp products threaten Ohio's marijuana industry
Flowers of hemp plants that contain less that 0.3 percent tetrahydrocannabinol (THC) the primary psychoactive substance in marijuana, to be used for student instruction at the Cleveland School of Cannabis, October 30, 2023, in Independence, Ohio. (Photo by Graham Stokes for Ohio Capital Journal. Republish photo only with original article.) Ohioans in the marijuana business, poison control workers, and religious organizations testified Tuesday in support of a bill that would regulate intoxicating hemp and drinkable cannabinoid products. Ohio Senate Bill 86 would require intoxicating hemp products to only be sold at adult-use dispensaries instead of allowing them to be sold at convenience stores, smoke shops, or gas stations. The bill would also impose a 15% tax on intoxicating hemp products and ban sales to anyone under 21. 'Ohio's legal cannabis industry is facing a growing crisis,' said Joshua Smith, the owner of Southern Ohio Botanicals, a licensed dispensary in Pike County. 'Fake, pop-up, poser dispensaries are exploiting loopholes in hemp laws to sell legitimate cannabis while misleading consumers into believing they are licensed establishments.' SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX Eleven people, including Smith, submitted testimony in support of S.B. 86 during Tuesday's Ohio Senate General Government Committee meeting. Ohio state Sens. Steve Huffman, R-Tipp City, and Shane Wilkin, R-Hillsboro, introduced S.B. 86, which would only allow intoxicating hemp products to be sold at dispensaries if the products have been tested and comply with standards for packaging, labeling, and advertising. It would only apply to products that can be ingested or inhaled. The 2018 U.S. Farm Bill says hemp can be legally grown if it contains less than 0.3% THC. Ohio is one of about 20 states that does have any regulations around intoxicating hemp products, according to an Ohio State University Drug Enforcement and Policy Center study from November 2024. 'These unregulated dispensaries demonstrate a failure in Ohio's marijuana program,' Smith said. 'Without oversight, we have no way of verifying where their cannabis is sourced from or if it has been properly tested for safety. Unlike regulated dispensaries, where all products are prepackaged and lab-tested, these rogue shops weigh out cannabis in front of customers with no quality control measures in place.' Fadi Boumitri, CEO of Ascension BioMedical, a licensed cannabis cultivator in Oberlin, said there are 10 shops within a 1.5 mile radius of his house that sells intoxicating hemp products. 'As a small company that is a cultivation only, we are disproportionately impacted by the large and growing market for intoxicating hemp products,' he said. Dr. Hannah Hays, medical director of the Central Ohio Poison Center and chief of toxicology at Nationwide Children's Hospital, said accidental cannabis-related poisonings reported to the Ohio Poison Centers has increased 20-fold for all age groups since 2019. Exposure to cannabinoid products, including Delta 8, has increased more than 330% for young children since 2021, she said. 'When young children access these products, they can experience severe symptoms including hallucinations, confusion, loss of consciousness, seizures, and respiratory failure,' Hays said. 'I've cared for children exposed to intoxicating hemp products who have experienced severe and prolonged symptoms, including coma.' Chris Lindsey, director of state advocacy and public policy for the American Trade Association for Cannabis and Hemp, shared test results of intoxicating hemp products he purchased at a Columbus convenience store last year. 'There was one that was a piece of candy and that one simple piece had 500 milligrams of THC in it, so that would put a horse in the hospital,' Lindsey said. 'You literally have to take just individual small bites of this candy to avoid overdose.' Will Kuehnle, an associate director with the Catholic Conference of Ohio, called the spread of intoxicating hemp products a threat to the 'moral fabric' of Ohio. 'These products, chemically altered to maximize intoxication, are marketed in ways that confuse consumers, evade regulatory oversight, and, most alarmingly, end up in the hands of minors,' he said. Follow Capital Journal Reporter Megan Henry on Bluesky. SUPPORT: YOU MAKE OUR WORK POSSIBLE
Yahoo
08-03-2025
- Business
- Yahoo
California voters passed an animal welfare proposition. Now, Congress looks to undo it
In 2018, California voters passed Proposition 12, mandating humane treatment for farm animals, specifically ensuring that breeding pigs are raised in conditions where they have enough room to turn around. The proposition prohibits the confinement of breeding pigs in cramped cages, which nearly immobilize animals. It is our position that the law is actually not as stringent as it should be and provides several loopholes that are abused by big business. I own Sweet Water Farm & Ranch Company, located in Columbia, Calif. We are proud to be a family-owned, regenerative ranching operation and we have always striven to implement practices that are good for our animals, our planet and our communities. With a focus on regenerative practices and improving biodiversity, we're committed to protecting not only our animals, but also the environment and public health. We primarily produce pasture-raised California Berkshire Pork, and we directly care for our pigs every day. Now, however, certain factions of the pork industry are seeking to undo laws like Prop. 12 via the U.S. Farm Bill. The U.S. House of Representatives Agriculture Committee passed Farm Bill language last year that would prohibit states from being able to regulate certain agriculture products sold within their borders. Wrongfully touted as a 'fix' to Prop. 12, this would — in actuality — hurt farmers, rural communities and the rights of states to set best policies and practices. We firmly support Prop. 12 and believe that any attempt to undermine or 'fix' it at the federal level is a step backward for animal welfare and the future of sustainable agriculture. Opinion Confining pigs to small spaces is not just harmful to the animals, it leads to less nutritious pork products and damages the environment in innumerable ways. Intensive confinement conditions are also a breeding ground for dangerous zoonotic diseases, which can spread from animals to humans, and this was one priority that drove Prop. 12's passage. Prop. 12 represents a long-overdue shift toward more humane, sustainable and healthy farming practices. It's better for us, better for animals and sets a standard for a better future. Working directly with our pigs, we understand their needs and behaviors. Stress-related health issues are a real concern when animals are confined to small spaces. By giving our pigs room to move on open pastures and exhibit natural behaviors, we reduce stress, injury and disease while increasing food quality and improving the natural world around us. Improving the living conditions of pigs — or any animal — also reduces the risk of disease outbreaks that harm our food system and public health. Congress' proposed 'fix' to Prop. 12 would weaken the admirable protections that California and other states have implemented, or make it easier for those who want to skirt the regulations. That is no fix at all, and for farmers like us, the danger is real. Such a move would undercut years of progress society has demanded toward improving animal welfare standards, and puts us — as conscientious farmers — at a greater competitive disadvantage. It could also erode significant investments that independent farmers and ranchers have made in creating sustainable, humane farming operations nationwide. Those operations create jobs, improve biodiversity, sequester carbon in depleted soils, rebuild rural communities and reduce disease outbreaks all while ensuring that a healthy, high-quality, American-made product ends up at the dinner table. The future of farming requires that we embrace the principles of regeneration and sustainability. Prop. 12 is part of a larger movement toward more ethical, environmentally responsible, health-conscious agriculture. More than a dozen states — red, blue and purple — have passed similar legislation. Undermining laws like Prop. 12 and the will of the millions of voters does a terrible disservice to Americans who care about where their food comes from and the treatment of animals. We stand firmly in support of Prop. 12 and encourage members of Congress to resist any attempts to weaken it. We appreciate Senator Alex Padilla's leadership in supporting this key law, and urge the entire California delegation to step up to protect Prop. 12 and the farmers and ranchers who maintain ethical, humane standards. Samuel Santry is the owner of Sweet Water Farm & Ranch Co ., located in Columbia, California, specializing in pasture-raised California Berkshire Pork.
Yahoo
07-03-2025
- Business
- Yahoo
Ohio bill would regulate the sale of intoxicating hemp products, limit where products would be sold
Flowers of hemp plants that contain less that 0.3 percent tetrahydrocannabinol (THC) the primary psychoactive substance in marijuana, to be used for student instruction at the Cleveland School of Cannabis, October 30, 2023, in Independence, Ohio. (Photo by Graham Stokes for Ohio Capital Journal. Republish photo only with original article.) A pair of Ohio Republican state senators want intoxicating hemp products to only be sold at adult-use dispensaries — not convenience stores, smoke shops, or gas stations. Ohio state Sens. Steve Huffman, R-Tipp City, and Shane Wilkin, R-Hillsboro, introduced Senate Bill 86, which would also impose a 15% tax on intoxicating hemp products sold at dispensaries and ban the sale of intoxicating hemp products to anyone under 21. 'Currently, intoxicating hemp products are untested, unregulated psychoactive products that can be just as intoxicating, if not more intoxicating than marijuana,' Wilkin said in his sponsor testimony to the Senate General Government Committee on Tuesday. The 2018 U.S. Farm Bill says hemp can be grown legally if it contains less than 0.3% THC. Ohio is one of about 20 states that does not have any regulations around intoxicating hemp products, according to an Ohio State University Drug Enforcement and Policy Center study from November 2024. Fifteen states ban these products. Seven states, including Michigan, regulate it like cannabis, while seven other states regulate it like consumer goods, according to the study. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'Given the lack of regulations, the intoxicating hemp industry has been able to confuse Ohio consumers and law enforcement by marketing themselves as 'dispensaries' with 'recreational marijuana,'' Huffman said in his testimony. Under the bill, intoxicating hemp products would only be sold at dispensaries if the products have been tested and comply with standards for packaging, labeling, and advertising. The bill would only apply to products that can be ingested or inhaled. 'To suppress the illicit market, this bill prohibits hemp products that are not sold in dispensaries from marketing the products as marijuana, using any terms associated with the sale of the product that would cause a consumer to infer the product is marijuana, or that the entity selling the product is a marijuana dispensary,' Huffman said in his testimony. He had a bill in the last General Assembly that would have banned the sale of all intoxicating hemp products, but it wasn't able to make it out of committee. Hemp business owners testified against the bill since it would end their livelihood, but they spoke in favor of regulations. S.B. 86 would also regulate drinkable cannabinoid products. 'The bill also authorizes the manufacture and sale of low-dose drinkable cannabinoid products in Ohio's dispensaries, craft breweries, bars and restaurants, and carry-outs, and imposes a $3.50 per gallon excise tax on manufacturers, similar to how we tax alcohol,' Huffman said in his testimony. Ohio Gov. Mike DeWine has repeatedly asked lawmakers to regulate or ban delta-8 THC products and Wilkin thanked DeWine for calling attention to this issue. 'The administration has been a consistent voice in warning of the dangers of this unregulated, untested, and dangerous market, and we're thankful for their efforts once again on this issue,' Wilkin said. Follow OCJ Reporter Megan Henry on Bluesky. SUPPORT: YOU MAKE OUR WORK POSSIBLE
